Fig. 1
From: Prevalence and spatio-demographic variability of nutrition-related health issues in Kiribati
Prevalence of biomarker-based health outcomes for adults. Percent observed in I-Kiribati adults by (a) body mass index classification, (b) anemia, (c) hypertension, (d) hyperglycemia, (e) hypercholesterolemia, (f) hypertriglyceridemia, and (g) diabetes separated by islands in order of population size at the time of sampling. Sample size of adults with biomarker status per island is stated on top of each panel. These are observed values (e.g., without accounting for potential demographic structures among islands). See Table S3 for the mean age of each biomarker by island. The reason for the difference in sample sizes (and number of islands included) for each biomarker relates to the research study design11 whereby anemia and anthropometry was assessed in all individuals, and all other biomarkers were assessed in a subset of individuals on only ten islands.
